![](https://investorshub.advfn.com/uicon/491452.png?cb=1557872961)
Tuesday, November 06, 2018 7:52:10 AM
RecoveryRx is what was entered.
IMO it doesn't match up well with the criteria given (see link).
https://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cdrh/cdrhinnovation/ucm609082.htm
RR is a post-surgical device. I just don't think it's what they are looking for in the challenge. Seems much more about end-user devices/products, and nothing at all related to post-op. I'll happily be wrong if it does get accepted. I will put the odds at 15% right now.
The company had said they were working on and going to submit a 510k on rr, and then did a bait and switch (IMO) and entered the challenge instead. If it's not accepted, who knows if they will end up doing one or not. They obviously should, and shoulda coulda woulda been done years ago at this point.
They should be notified by end of the month on if they got accepted or not, and give an update regardless. JMHO but they aren't known to be the best communicators. gl
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM